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This article has an accompanying continuing medical education activity on page e13. Learning Objective: Upon completion of this
CME exercise and reading of the associated paper, successful learners will be able to compare the rates of presentation of fertility
problems in women with and without celiac disease.BACKGROUND & AIMS: Studies have associated infertility with
celiac disease. However, these included small numbers of
women attending infertility specialist services and subse-
quently screened for celiac disease, and therefore may not have
been representative of the general population. We performed a
large population-based study of infertility and celiac disease in
women from the United Kingdom. METHODS: We identiﬁed
2,426,225 women with prospective UK primary care records
between 1990 and 2013 during their child-bearing years from
The Health Improvement Network database. We estimated age-
speciﬁc rates of new clinically recorded fertility problems
among women with and without diagnosed celiac disease.
Rates were stratiﬁed by whether celiac disease was diagnosed
before the fertility problem or afterward and compared with
rates in women without celiac disease using Poisson regression,
adjusting for sociodemographics, comorbidities, and calendar
time. RESULTS: Age-speciﬁc rates of new clinically recorded
fertility problems in 6506 women with celiac disease were
similar to the rates in women without celiac disease (incidence
rate ratio, 1.12; 95% conﬁdence interval, 0.88–1.42 among
women age 25–29 years). Rates of infertility among women
without celiac disease were similar to those of women with
celiac disease before and after diagnosis. However, rates were
41% higher among women diagnosed with celiac disease when
they were 25–29 years old, compared with women in the same
age group without celiac disease (incidence rate ratio, 1.41;
95% conﬁdence interval, 1.03–1.92). CONCLUSIONS: Women
with celiac disease do not have a greater likelihood of clinically
recorded fertility problems than women without celiac disease,
either before or after diagnosis, except for higher reports
of fertility problems between 25–39 years if diagnosed with
CD. These ﬁndings should assure most women with celiac
disease that they do not have an increased risk for fertility
problems.Keywords: Food Allergy; Gluten; Pregnancy; Risk Factor.
Watch this article’s video abstract and others at http://bit.ly/1q51BlW.Abbreviations used in this paper: BMI, body mass index; CD, celiac dis-
ease; CI, conﬁdence interval; IQR, interquartile range; IRR, incidence rate
ratio; THIN, The Health Improvement Network.
© 2014 by the AGA Institute Open access under CC BY-NC-ND license.Scan the quick response (QR) code to the left
with your mobile device to watch this article’s
video abstract and others. Don’t have a QR code
reader? Get one by searching ‘QR Scanner’ in
your mobile device’s app store.0016-5085/
http://dx.doi.org/10.1053/j.gastro.2014.08.025Celiac disease (CD) affects approximately 1% of thepopulation in North America and Western Europe,1–3
of whom 0.2% are clinically diagnosed, with women consti-
tuting approximately 60%–70% of the clinically diagnosed
population.4 The literature reports several mechanisms
through which CD potentially could affect a woman’s fertility
such as the presence of abnormal villous structure in the in-
testine and malabsorption of the nutrients leading to nutri-
tional deﬁciencies (eg, in zinc, iron, folate, and selenium).5
These nutritional deﬁciencies are said to affect fertility,
however, there is no conclusive evidence on the extent to
which this may cause fertility problems in CD.6 A lower level
of ghrelin and leptin in women with CD also has been re-
ported to play a role in fertility problems.7 In addition, a
shortened reproductive period with delayed menarche and
early menopause also has been cited as an explanation for the
reported increase in fertility problems related to CD.8 On the
contrary, a study based on 99 women being evaluated for
infertility in Sardinia found no delay in the age of menarche in
women with diagnosed CD (mean age at menarche, 11.8 y).9
Based on these explanations, several small studies over
the years have assessed the link between CD and fertility
problems, with some reporting a higher prevalence of CD in
women seeking fertility treatments10,11 and some showing
no increase compared with the general population.9,12,13
Some of these studies found that although the prevalence
of CD was not higher in women with infertility, when
restricted to only women with unexplained infertility, the
prevalence of CD was signiﬁcantly higher than in the general
population,9,10,14 whereas others did not ﬁnd any signiﬁcant
association even with unexplained infertility.12,13 These
studies all were conducted on a very small number of
women (the largest study included 535 women) primarily
attending infertility specialist services, which represents a
very selective group of women in the general population. In
addition, these studies did not distinguish the burden of
fertility problems in women with diagnosed from
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small studies, a wide variety of reviews highlight infertility
as one of the key nongastrointestinal manifestations in
CD.15–17 We therefore performed a large population-based
study to compare the rates of new clinically recorded
fertility problems in a group of women with and without
celiac disease that are representative of the UK population.Methods
Data Source and Study Population
In the United Kingdom, any ﬁrst contact or treatment from
specialist infertility services requires a referral from a woman’s
primary care doctor, commonly known as the general practi-
tioner; this is the ﬁrst clinical contact for assessment of fertility
problems. Therefore, we used The Health Improvement Network
(THIN), a UK database of anonymized electronic primary care
records to derive our study population. THIN has been shown to
have a high validity of recorded diagnoses, medical events, and
prescriptions.18 It has been used previously to assess fertility
problem reporting at a population level,19 and the overall and age-
speciﬁc fertility rates in THIN are broadly comparable with na-
tional fertility rates.20 The version of THIN used for the purpose of
this study contained longitudinal records of prospectively
collected health information from570 general practices across the
United Kingdom, covering 6% of the total UK population.21 Our
cohort included all women of potential childbearing age (15–49 y)
who contributed 1 or more years of active registration time be-
tween January 1990 and January 2013 to a general practice
providing data to THIN. We selected women aged 15–49 years in
accordance with the World Health Organization denominator for
calculating the prevalence of infertility in women.22
Deﬁning Celiac Disease
We identiﬁed each woman as having CD if she had a
recorded diagnosis of CD in her general practice record using
Read codes (clinically coded thesauraus used by general prac-
titioners in the UK to record medical information) (Read codes:
J690.00 for CD, J690.13 for gluten enteropathy, J690.14 for
sprue-nontropical, J690100 for acquired CD, and J690z00 for
CD NOS) with or without accompanying evidence of either
gluten-free dietary prescriptions or dermatitis herpetiformis.
Each woman with CD was assigned a date of diagnosis corre-
sponding to the date of her ﬁrst record of CD or the date of her
ﬁrst prescription of a gluten-free product (if present). Women
with CD were classiﬁed further as having the diagnosis after the
ﬁrst fertility problem record (undiagnosed CD) or before
(diagnosed CD). The method used to deﬁne CD has been vali-
dated previously in general practice databases with a positive
predictive value ranging between 81% and 89%.23 Lastly, we
used longitudinally recorded information on women’s disease
symptoms and biological measurements (weight loss, diarrhea,
or anemia in the year before celiac disease diagnosis) to give a
proxy metric for women with more severe symptomatic CD.
Our comparison group consisted of women of childbearing
age without any recorded diagnoses of CD or dermatitis her-
petiformis in their primary care data. Women who received a
gluten-free prescription in the absence of any CD or dermatitis
herpetiformis diagnosis at any point during the study period
also were excluded.Deﬁning Fertility Problems
Fertility problems in women were deﬁned using read codes
for fertility investigations (eg, 3189.00 for infertility investiga-
tion female), interventions (eg, 7M0h.00 for in vitro fertiliza-
tion), speciﬁc (eg, K5B0000 for primary anovulatory infertility)
or nonspeciﬁc diagnoses (eg, 1AZ2.11 for infertility problem),
specialist referrals (eg, 8HTB.00 for referral to fertility clinic), or
drug prescriptions used exclusively to treat fertility problems in
women (principally clomiphene citrate).24 We considered the
date of the ﬁrst record of a fertility problem during the study
period to be the date of a new clinically recorded fertility
problem. A detailed description of how we deﬁned incident
records of fertility problems is available elsewhere.19 This
deﬁnition of new clinically recorded fertility problems was
shown in our previous work to generate age-speciﬁc rates with
comparable patterns with those reported by the Human Fertil-
isation and Embryology Authority, which reports population-
based, age-speciﬁc rates of women receiving specialized
fertility treatments in the United Kingdom.25 Code lists are
available from the authors upon request.
Deﬁning Other Variables
Information on women’s sociodemographic factors
including age, socioeconomic status, as measured by quintiles
of the Townsend Deprivation Index, the most recent smoking
status record, and body mass index (BMI) before the ﬁrst
fertility problem record was extracted. For women who did not
have a recorded fertility problem, a random date was generated
(pseudodiagnosis date) as a reference to extract the most
recent recording on smoking status and BMI. Women were
classiﬁed as smokers and nonsmokers (including never
smokers and ex-smokers). If the medical code did not clearly
indicate whether women were smokers or not, they were
included in the missing/unknown category. Information on BMI
was categorized as follows: underweight (<18.5 kg/m2),
normal (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/m2),
obese (30 kg/m2), and missing BMI. Information on other
autoimmune disorders including type 1 diabetes, rheumatoid
arthritis, and thyroid disorders also was extracted.
Statistical Analysis
We described and compared baseline characteristics among
women with and without CD using means, t tests, proportions,
and chi-square tests. The distribution of all types of fertility
problems across the study period was examined in both women
with CD and women without CD. We estimated the incident rates
of new clinically recorded fertility problems as the number ofﬁrst
recorded fertilityproblemper1000person-years. Female fertility
is known to decrease with age26,27; therefore, we stratiﬁed the
rates of clinically recorded fertility problems by 5-year age
groups. We used lexis expansion28 to construct an age-cohort
model in which women could contribute person time to more
than one age group. Given that the prevalence of CD has increased
over time29 we used an additional lexis expansion to split the
study time by calendar year. We calculated age-speciﬁc incident
rates of clinically recorded fertility problems in women with CD
compared with women without CD. We then used Poisson
regression to calculate the incidence rate ratios (IRRs) and cor-
responding 95% conﬁdence intervals (CIs) for these compari-
sons, adjusting for socioeconomic status (quintiles of Townsend
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autoimmune disorders. The age-speciﬁc rates of new clinically
recorded fertility problems also were assessed in women with
undiagnosed and diagnosed CD and in women with symptomatic
celiac disease. These rates then were compared with the rates in
women without CD, and IRRs (95% CIs) were calculated in a
similar fashion as described earlier.
Finally, the National Institute for Health and Clinical
Excellence recommends that women with fertility problems
should be screened for CD.30 Therefore, women are more likely
to be screened for CD if they report a fertility problem. To
assess this potential ascertainment of CD in relation to fertility
problems we assessed the timing of new clinically recorded
fertility problems in women in relation to their CD diagnosis to
calculate the time difference between the 2 events.Sensitivity Analysis
To increase the speciﬁcity of our CD deﬁnition, we restricted
it to include only women who had both a read code for CD and a
gluten-free prescription. Age-speciﬁc rates of new clinically
recorded fertility problems were recalculated in women with CD
and in women without CD based on this deﬁnition.Ethical Approval
Ethical approval for this study was obtained from The
Health Improvement Network Scientiﬁc Research Committee
(EPIC Data Company) (reference number 11-027A).Table 1.Baseline Characteristics of the Study Population
Celiac disease (N ¼ 6506
Mean SD
Age at ﬁrst report of fertility problem 33.4 6.2
(n (%)) n %
Townsend score
Quintile 1 (least deprived) 1681 25.8
Quintile 2 1356 20.8
Quintile 3 1242 19.1
Quintile 4 1070 16.4
Quintile 5 (most deprived) 711 10.9
Missing 446 6.9
Most recent smoking status
at ﬁrst report of fertility problemb
Nonsmoker 4242 65.2
Smoker 802 12.3
Unknown/missing 1462 22.5
Most recent BMI at ﬁrst report
of fertility problem, kg/m2b
Underweight (<18.5) 372 5.7
Normal (18.5–24.9) 2911 44.7
Overweight (25.0–29.9) 990 15.2
Obese (30) 607 9.3
Missing 1626 24.9
Type 1 diabetes 207 3.2
Rheumatoid arthritis 136 2.1
Thyroid disorder 694 10.7
aP value obtained from t test.
bA random index date (pseudodiagnosis date) was generated fResults
Study Population
Of the total population of 2,426,225 potentially fertile
women contributing 15,236,530 years of follow-up time, 6506
(0.3%) women had a diagnosis of CD. The median follow-up
time in the women with CD and in the women without CD
was 6.5 person-years (interquartile range [IQR], 3.1–11.4) and
4.6 person-years (IQR, 2.4–9.0), respectively. The mean age at
theﬁrst clinically recorded fertilityproblemwas slightlyhigher
in women with CD compared with women without CD (mean
difference, 0.61; 95%CI, -0.13 to 1.34; P¼ .107), however, this
difference was not statistically signiﬁcant (Table 1). Women
withCDweremoreafﬂuent comparedwithwomenwithout CD
(25.8% compared with 20.9%, respectively, in quintile 1) and
also more likely to be underweight (5.7% in women with CD
comparedwith3.3% inwomenwithout CD). The prevalence of
smoking also was slightly lower in women with CD compared
with women without CD (12.3% vs 17.0%; P < .001). In
addition, womenwith CD also had a higher prevalence of other
autoimmune diseases compared with the non-CD group (P for
all comorbidities < .001).
Of the 6506 women with CD, 290 (4.4%) had clinically
recorded fertility problems, and of the 2,419,718 women
without CD, 98,366 (4.1%) had clinically recorded fertility
problems. When all codes relating to fertility problems
appearing in women’s primary care records were assessed,
there was no statistically signiﬁcant difference in the) No celiac disease (N ¼ 2,419,718)
P value,
chi-squared testMean SD
32.8 6.4 .107a
n %
505,211 20.9
439,541 18.2
470,933 19.5 <.001
460,980 19.0
341,380 14.1
201,673 8.3
1,330,425 54.9 <.001
412,184 17.0
677,109 27.9
79,334 3.3
950,153 39.2 <.001
388,762 16.1
261,830 10.8
739,639 30.6
11,345 0.5 <.001
18,737 0.8 <.001
74,947 3.1 <.001
or women without recorded fertility problems.
Table 2.Rates of New Clinically Recorded Fertility Problems in Women With Celiac Disease, Without Celiac Disease,
Undiagnosed and Diagnosed Celiac Disease, and Incidence Rate Ratios
Maternal age, y
Incident record of fertility
problem Person-years
Rate per 1000 person-years
(95% CI) IRR (95% CI)a
No celiac disease (N ¼ 2,419,718)
Overall rate 98,366 15,186,536 6.5 (6.4–6.5)
15–19 1372 1,627,802 0.8 (0.7–0.9)
20–24 9550 1,961,104 4.8 (4.7–5.0)
25–29 22,562 2,211,743 10.2 (10.0–10.3) Reference
30–34 29,473 2,328,794 12.6 (12.5–12.8)
35–39 21,698 2,390,721 9.0 (8.9–12.8)
40–44 9905 2,389,596 4.1 (4.0–4.2)
45–49 3806 2,276,776 1.7 (1.6–1.8)
Celiac disease (N ¼ 6506)
Overall rate 290 49,994 5.8 (5.2–6.5) 0.84 (0.75–0.95)
15–19 2 3217 0.6 (0.2–2.4) 0.78 (0.20–3.15)
20–24 20 3968 5.0 (3.2–7.8) 0.98 (0.63–1.52)
25–29 67 5357 12.5 (9.8–15.8) 1.12 (0.88–1.42)
30–34 84 7215 11.6 (9.4–14.4) 0.87 (0.70–1.08)
35–39 70 9068 7.7 (6.1–9.7) 0.83 (0.65–1.04)
40–44 38 10,387 3.6 (2.6–5.0) 0.85 (0.62–1.17)
45–49 9 10,783 0.8 (0.4–1.6) 0.50 (0.26–0.96)
Undiagnosed CD (N ¼ 122)
Overall rate 122 23,608 5.2 (4.3–6.2) 0.76 (0.64–0.91)
15–19 0 1600 0 -
20–24 11 1828 6.0 (3.3–10.8) 1.11 (0.62–2.01)
25–29 27 2757 9.8 (6.7–14.3) 0.86 (0.59–1.25)
30–34 37 3859 9.6 (6.9–13.2) 0.74 (0.54–1.03)
35–39 30 4472 6.7 (4.7–9.6) 0.78 (0.55–1.12)
40–44 9 4665 1.9 (1.0–3.7) 0.47 (0.24–0.91)
45–49 8 4424 1.8 (0.9–3.6) 1.04 (0.52–2.09)
Diagnosed CD (N ¼ 168)
Overall rate 168 26,386 6.4 (5.5–7.4) 0.91 (0.79–1.07)
15–19 2 1616 1.2 (0.3–4.9) 1.54 (0.36–6.20)
20–24 9 2139 4.2 (2.2–8.1) 0.86 (0.45–1.65)
25–29 40 2600 15.4 (11.3–20.9) 1.41 (1.03–1.92)
30–34 47 3356 14.0 (10.5–18.6) 1.01 (0.76–1.34)
35–39 40 4596 8.7 (6.4–11.9) 0.86 (0.63–1.17)
40–44 29 5721 5.1 (3.5–7.3 ) 1.14 (0.79–1.64)
45–49 1 6358 0.2 (0.02–1.1) 0.10 (0.01–0.69)
Symptomatic CD (N ¼ 1143)
Overall rate 43 10,261 4.2 (3.1–5.6) 0.60 (0.45–0.81)
15-19 0 589 0 -
20–24 3 687 4.4 (1.4–13.5) 0.84 (0.27–2.61)
25–29 6 1000 6.0 (2.7–13.3) 0.53 (0.23–1.17)
30–34 14 1491 9.4 (5.6–15.8) 0.69 (0.41–1.18)
35–39 12 1930 6.2 (3.5–10.9) 0.67 (0.38–1.18)
40–44 7 2250 3.1 (1.5–6.5) 0.71 (0.34–1.50)
45–49 1 2312 0.4 (0.1–3.1) 0.25 (0.04–1.81)
aAdjusted for Townsend deprivation index quintiles, smoking status, body mass index, type 1 diabetes, thyroid disorder,
rheumatoid arthritis, and calendar year.
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referrals, or diagnoses between women with and without
CD (Supplementary Table 1).
Age-speciﬁc rates in women with CD compared
with women without CD. Table 2 shows the rates of new
clinically recorded fertility problems in women with and
without CD by 5-year age groups. In women with CD, the
rate of new clinically recorded fertility problems was highest
in the 25–29 year age group (12.5 per 1000 person-years),
and in women without CD the rate was highest in the30–34 year age group (12.6 per 1000 person-years). Across
all age groups, however, there were no statistically signiﬁ-
cant differences between the rates of new clinically recorded
fertility problems in women with and without CD (eg, IRR in
the 25–29 year age group, 1.12; 95% CI, 0.88–1.42; IRR in
the 30–34 year age group, 0.87; 95% CI, 0.70–1.08).
Age-speciﬁc rates in diagnosed and undiagnosed
CD. Of the 290 women who had CD and a recorded fertility
problem, 122 (42%) were classiﬁed as having undiagnosed
CD and 168 (58%) were classiﬁed as having diagnosed CD
Figure 1. Timing of a new clinically recorded fertility problem in relation to celiac disease diagnosis (N ¼ 290).
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The diagnosis of CD happened at a median of 2 months after
the fertility problem (IQR, 4 years before, 2.7 years after).
Figure 1 shows the time of new clinically recorded fertility
problems in relation to the CD diagnosis. Approximately a
quarter of the fertility problems were recorded within a
year before or after the CD diagnosis, with 5% being
recorded within a year before the fertility problem and 19%
within a year after the fertility problem.
Overall, the age-speciﬁc rates of new clinically recorded
fertility problems were higher in women with diagnosed CD
compared with women with undiagnosed CD (15.4 per 1000
person-years in diagnosed CD compared with 9.8 per 1000
person-years in undiagnosed CD in the 25–29 year age
group) (Table 2). There was no statistically signiﬁcant dif-
ference between the rates of new clinically recorded fertility
problems in women with both undiagnosed and diagnosed
CD compared with women without CD, except for the 25–29
year age group, in which women with diagnosed CD were
41% more likely to have new clinically recorded fertility
problems compared with women without CD (IRR, 1.41;
95% CI, 1.03–1.92). However, the absolute excess risk was
only 0.5% (5.2 per 1000 person-years).
Age-speciﬁc rates in women with symptomatic
CD. Of the 6506 women with celiac disease, 1143 (17.6%)
were recorded as symptomatic (with weight loss, diarrhea, oranemia) in the year before diagnosis. The age-speciﬁc rates of
new clinically recorded fertility problems in this subset of
womenwith symptomatic celiac diseasewere not statistically
signiﬁcantly different compared with women without celiac
disease. The overall rate was found to be 40% lower, how-
ever, the absolute risk difference was only 2.3% (Table 2).
Sensitivity Analysis
Of 6506 women with CD, 4649 (71.4%) had received a
gluten-free prescription. Of these women, 211(4.5%) had
clinically recorded fertility problems, which was almost
exactly the same as in the overall population. The age-speciﬁc
rates of new clinically recorded fertility problems were very
similar to the main results, with no statistically signiﬁcant in-
crease in the rates of new clinically recorded fertility problems
in women with CD based on the more speciﬁc criteria
compared with women without CD (Supplementary Table 2).Discussion
Principal Findings
In this large population-based contemporary cohort
study from the United Kingdom, we analyzed more than 2
million women of childbearing age, of whom 0.3% were
diagnosed with CD.
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lems in primary care in women with and without CD is very
similar. In addition, the rates of new clinically recorded
fertility problems in women with diagnosed and undiag-
nosed CD were similar and comparable with the rates in
women without CD except for the 25–29 year age group in
women with diagnosed CD, who had a 40% relative increase
in fertility problems compared with women without CD,
which corresponded to an absolute excess risk of 0.5%.Strengths and Limitations
We assessed the association between celiac disease and
fertility problems with data on over 2 million women over a
period of 20 years. Given the natural decrease in fertility
with age, an overall prevalence would mask the effects of
increasing association between CD and fertility problems.
Therefore, we have presented age-speciﬁc rates of new
clinically recorded fertility problems in women, which are
more meaningful in planning interventions. To account for
the increasing prevalence of CD29 and reporting of fertility
problems19 over time, we also adjusted for calendar year
and also for other potential confounders such as smoking,
socioeconomic status, BMI, and other autoimmune diseases
known to be common in women with CD and associated
with fertility problems.31
Previous studies have identiﬁed women with CD from
specialist infertility clinics9,10,14,32 or obstetrics and gyne-
cology units in the hospital.11–13 This may be only a selec-
tive group of women because not all women who experience
difﬁculties in conceiving seek medical help. The proportion
of women seeking medical help for their fertility problem in
the United Kingdom ranges from 70% to 85%.33,34 Studies
from the United Kingdom report that between 30% and
49% of women reporting fertility problems are given re-
ferrals or undergo fertility treatments.33,35 Therefore,
women selected from specialist fertility clinics may be
signiﬁcantly different from the majority of women experi-
encing fertility problems, especially in terms of socio-
demographics, making the previous studies highly prone to
selection bias. By contrast, we identiﬁed women from
routinely collected primary care data in which the women
initially will consult for fertility problems before going for
specialized treatments or investigations. Primary care data
therefore provide a more complete picture of the extent and
distribution of clinically recorded fertility problems at a
population level while minimizing the potential for selection
bias. It could be argued, however, that women with CD in
our population are more likely to have fertility problems
that require specialist medical treatment than women
without CD. When we compared the available information
on coding of fertility problems, this was not supported; we
noted no important differences in types of infertility, treat-
ments, and referrals between women with and without CD.
Because we did not have detailed information on sero-
logic tests and histology of the small bowel to conﬁrm CD,
we used speciﬁc medical read codes instead to identify
women with CD in the general population. The method used
to deﬁne CD has been validated previously in generalpractice databases,23 therefore we believe the ascertainment
of CD in our study is likely to be good. Other recent studies
also have made use of read codes in primary care data to
identify cases of CD, reiterating that this method to identify a
CD population is valid.36,37 When we further increased the
speciﬁcity of our CD diagnosis by restricting our analysis
only to cases with supporting evidence of a gluten-free
prescription, our estimates remained broadly unchanged.
Approximately 30% of the women with CD did not have
any record of a gluten-free prescription in our study. Gluten-
free prescriptions are considerably costly when prescribed
on the UK National Health Service compared with similar
products purchaseddirectly.38 Therefore,womenmayendup
purchasing gluten-free products directly, in which case there
will be noprimary care data recorded on these purchases. Our
study also lacked data on compliance with a gluten-free diet.
However, similar to most CD studies, we assumed that all
women with diagnosed CD are broadly compliant with a
gluten-free diet, which seems reasonable given previous ev-
idence suggesting that complete nonadherence to a gluten-
free diet is uncommon among patients with CD.39
We must acknowledge that approximately 1% of women
in the United Kingdom have serologic evidence of CD40 and
therefore it is likely that there are women with undiagnosed
CD among our general population comparison group. It
therefore is possible that the presence of these women
could have increased the rate of fertility problems in our
comparison group if there was truly an increased risk of
infertility among women with undiagnosed CD as has been
implied previously.10,11,14,41 However, against that hypoth-
esis, our analysis of the women with undiagnosed CD
showed that, if anything, their rates of clinically recorded
fertility problems were even lower than in the women with
diagnosed CD in almost all of the age groups we studied.
Finally, there were communication delays between sec-
ondary and primary care.42 Although the exact time for this is
unknown, there may be inaccuracies in the recording of the
exact date of diagnosis of CD, which may have resulted in the
misclassiﬁcation of some diagnosed cases as being undiag-
nosed. Nevertheless, the rates of fertility problems in both
diagnosed and undiagnosed CD were found to be very similar,
and alsowere comparablewith the rates inwomenwithout CD.Comparison With Current Literature
Results from the limited studies assessing CD in women
with fertility problems have been inconsistent. Some studies
have reported a higher prevalence of CD in women under-
going fertility treatments compared with controls,10,11 and
some have shown no statistically signiﬁcant difference be-
tween the prevalence of CD in women undergoing fertility
treatment and controls.9,12,13 The small sample sizes (<600
women) and a very selective baseline population in these
studies makes sensible comparisons with our study very
difﬁcult. Another important consideration when comparing
our ﬁndings with the previous studies is that these studies
captured women at more advanced stages in the manage-
ment of fertility problems (ie, specialist fertility clinics or
where women already had a speciﬁc diagnosis; eg,
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women who had fertility problems recorded in primary care
but may not have gone on to receive specialist fertility
services. Furthermore, the age-speciﬁc rates calculated in
our study are not directly comparable with the prevalence
estimates from previous studies.
Some studies, however, have reported fertility rates in
womenwith and without CD, using the number of children as
an indicator of fertility. For example, a case-control study
that included 68 women with CD and 68 controls from
England found that women with CD had a mean number of
children ¼ 1.9 (SD, 0.9) children compared with a mean
number of children¼ 2.5 (SD, 1.2) in controls, suggesting that
the fertility proﬁle of women with CD was slightly inferior to
the general population, and that it improved after the diag-
nosis and treatment of CD (0.5 children; SD, 0.9) compared
with controls (0.7; SD, 1.2).41 In contrast, a Swedish
population-based study including 11,945 CD cases and
51,109 controls found slightly higher cumulative numbers of
children in the CD population compared with controls and a
fertility hazard ratio of 1.03 (95% CI, 1.01–1.05), with a
similar fertility hazard ratio for women younger than age 18,
women between ages 18 and 44, and women older than age
45.43 Similarly, a population-based study using the UK pri-
mary care data showed fertility rates in CD and non-CD
women to be very similar.44 Our ﬁndings mirror these pat-
terns because they show no statistically signiﬁcant differ-
ences in the age-speciﬁc rates of new clinically recorded
fertility problems in women with and without CD. Further-
more, no differences were observed in the rates of reporting
of fertility problems before and after the diagnosis of CD.
Rates of reporting fertility problems were slightly higher in
younger women with diagnosed CD between the ages of
25–29 (1.41; 95% CI, 1.03–1.92); however, this effect did not
hold for women in other age groups. Furthermore, approxi-
mately 50% of the fertility problems reported in womenwith
diagnosed CD in the 25–29 year age group were within 2
years of CD diagnosis, again indicating that the small increase
in clinically recorded fertility problems we observed in those
ages 25–29 years could well be related to the ascertainment
of CD or vice versa rather than depicting a causal relationship.
It also is worth noting that although the relative riskwas 40%
higher in women with diagnosed CD, the absolute excess risk
was calculated to be only 0.5%. The overall rate of new clin-
ically recorded fertility problems in women with symptom-
atic CDwas found to be slightly lower than the rates inwomen
without CD. These lower rates may be explained by an
increased focus on resolving celiac symptoms before women
try to conceive or the lack of more speciﬁc metrics of disease
severity in our data.Conclusions
The current evidence regarding CD in small groups of
women with unexplained infertility from a small number of
studies has been generalized to raise concern among all
women with CD by highlighting women with infertility as
one of the associated conditions in CD.17,45,46 Although un-
diagnosed CD is likely to be an underlying cause ofunexplained infertility for some women, our ﬁndings indi-
cate that most women with celiac disease, either undiag-
nosed or diagnosed, do not have a substantially greater
likelihood of clinically recorded fertility problems than
women without CD. Therefore, screening when women
initially present with fertility problems may not identify a
signiﬁcant number of women with CD, beyond the general
population prevalence. This may not always apply to sub-
groups of women with severe celiac disease. However, in
terms of the clinical burden of fertility problems at a pop-
ulation level, these ﬁndings should be reassuring for women
with CD and all stakeholders involved in their care.
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Supplementary Table 1.Detailed Description of Fertility Problem Read Code Categories Appearing in the Clinical Records for
Cases of Fertility Problems
Celiac disease (N ¼ 290)a No celiac disease (N ¼ 98,366)b P value for overall category
Drug treatment 55 (19.0%) 16,843 (17.1%) .406
Chorionic gonadotropin 12 2273
Clomiphene citrate 45 14,495
Follitropin a and b 7 807
Human menopausal gonadotropin 2 359
Urofollitropin 6 1242
Investigations 41 (14.1%) 14,562 (14.8%) .750
Ovulation tests 1 261
Methylene blue tubal test 0 66
Nonspeciﬁc infertility investigations 40 14,290
Interventions 49 (16.9%) 18,001 (18.3%) .537
Counseling 22 8803
Surgical intervention 3 419
In vitro fertilization 15 4650
Intrauterine insemination 0 18
Nonspeciﬁc management codes 19 6682
Referrals 40 (13.8%) 12,758 (13.0%) .677
Diagnoses 230 (79.3%) 77,270 (78.6%) .754
Infertility: cervical origin 0 4
Infertility: ovulatory origin 1 556
Infertility: pituitary hypothalamic 0 5
Infertility: tubal origin 0 125
Infertility: uterine origin 0 6
Infertility: vaginal origin 0 9
Infertility: nonspeciﬁc 229 76,622
aPercentage of 290.
bPercentage of 98,366, total may not be equal to the sum of all columns because each woman may have had more than 1
code.
Supplementary Table 2.Age-Speciﬁc Rates (95% CI) of New Clinically Recorded Fertility Problems in Women With and
Without Celiac Disease and Incidence Rate Ratios (95% CI) Using a Restricted Deﬁnition of CD
Age, y
Celiac disease (N ¼ 4649) No celiac disease (N ¼ 2,419,718)
IRR (95% CI)a
Incident record of
fertility problem
Person
time
Rate per 1000 person-
years (95% CI)
Incident record of
fertility problem
Person
time Rate (95% CI)
Overall 211 37,400 5.6 (4.9–6.4) 98,366 15,186,536 6.5 (6.4–6.5) 0.85 (0.74–0.98)
15–19 2 2331 0.8 (0.2–3.4) 1372 1,627,802 0.8 (0.7–0.9) 1.44 (0.36–5.77)
20–24 12 2699 4.4 (2.5–7.8) 9550 1,961,104 4.8 (4.7–5.0) 0.93 (0.52–1.68)
25–29 50 3690 13.5 (10.3–17.9) 22,562 2,211,743 10.2 (10.0–10.3) 1.08 (0.78–1.47)
30–34 61 5304 11.5 (8.9–14.7) 29,473 2,328,794 12.6 (12.5–12.8) 0.87 (0.67–1.14)
35–39 52 6834 7.6 (5.8–9.9) 21,698 2,390,721 9.0 (8.9–12.8) 0.88 (0.66–1.16)
40–44 28 7968 3.5 (2.4–5.1) 9905 2,389,596 4.1 (4.0–4.2) 0.90 (0.62–1.32)
45–49 6 8572 0.7 (0.3–1.6) 3806 2,276,776 1.7 (1.6–1.8) 0.46 (0.19–1.09)
aAdjusted for Townsend deprivation index quintiles, smoking status, body mass index, type 1 diabetes, thyroid disorder,
rheumatoid arthritis, and calendar year.
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